Search for: "ELI LILLY " Results 81 - 100 of 2,172
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
29 Jul 2010, 9:59 pm by Patent Docs
Eli Lilly & Co., the Federal Circuit affirmed a finding that claims of Lilly's U.S. [read post]
19 Apr 2016, 7:43 am by Gene Quinn
The Eli Lilly brief was filed in support of the petitioner, Sequenom. [read post]
9 Jun 2009, 11:39 am
"More than 100 African American employees have filed declarations outlining the toll of Eli Lilly's discrimination on them and their families. [read post]
21 Oct 2014, 8:34 am by Legal Profession Prof
A former Eli Lilly attorney was suspended for 90 days by the Indiana Supreme Court for taking confidential materials with him when he left. [read post]
12 Nov 2009, 6:43 am
The AP reports, "Utah has agreed to a $24 million settlement with Eli Lilly & Co. over claims the drugmaker engaged in off-label marketing of the anti-psychotic drug Zyprexa [olanzapine]," according to Attorney General Mark Shurtleff. [read post]
10 Nov 2011, 11:11 am
Indianapolis IN - Trademark lawyers for Eli Lilly and Company of Indianapolis, Indiana filed a trademark infringement suit in the Southern District of Indiana alleging Yanchep Veterinary Clinic, Proprietary Limited Company, Petsvetshop, Proprietary Limited Company,, Paul Sorensen and Dr. [read post]
27 Mar 2013, 9:41 pm by Patent Docs
The compound in question, olanzapine, was encompassed by an earlier Eli Lilly patent -- a 'genus patent'. [read post]
14 Jun 2022, 2:47 pm by AMANDA JAMES - MEDCITY NEWS
The post State High Court Says Eli Lilly Warned Doctor Of Drug Risks, Didn’t Need To Warn Patient appeared first on Above the Law. [read post]
6 Sep 2010, 9:48 pm by Patent Docs
Noonan -- The old proverb "success has many fathers, while failure is an orphan" comes to mind when considering the Federal Circuit's decision in Eli Lilly & Co. v. [read post]
30 Sep 2010, 9:59 pm by Patent Docs
Noonan -- The Biotechnology Industry Organization (BIO) has joined the chorus of amici urging the Federal Circuit to rehear en banc (and overturn) a panel decision affirming an invalidity finding of Eli Lilly's U.S. [read post]